Literature DB >> 20889122

Metabolic dysfunction in the pathogenesis of pulmonary hypertension.

Lewis J Rubin1.   

Abstract

Pulmonary artery hypertension is characterized by proliferation in the resistance vessels. A recent study in Science Translational Medicine (Sutendra et al., 2010) found that increased fatty acid oxidation and a shift in the glycolysis/glucose oxidation ratio may be central to the pathogenesis of this process, suggesting that these abnormalities comprise novel treatment targets.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID: 20889122     DOI: 10.1016/j.cmet.2010.09.006

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  4 in total

1.  Protein Expression by Human Pulmonary Artery Smooth Muscle Cells Containing a BMPR2 Mutation and the Action of ET-1 as Determined by Proteomic Mass Spectrometry.

Authors:  Chunxiang Yao; Jun Yu; Linda Taylor; Peter Polgar; Mark E McComb; Catherine E Costello
Journal:  Int J Mass Spectrom       Date:  2015-02-15       Impact factor: 1.986

2.  (1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.

Authors:  Taijie Lin; Jinping Gu; Caihua Huang; Suli Zheng; Xu Lin; Liangdi Xie; Donghai Lin
Journal:  Dis Markers       Date:  2016-01-18       Impact factor: 3.434

Review 3.  Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism.

Authors:  Ilias Mylonis; George Simos; Efrosyni Paraskeva
Journal:  Cells       Date:  2019-03-03       Impact factor: 6.600

4.  Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China.

Authors:  Chenyang Chen; Fei Luo; Panyun Wu; Yiyuan Huang; Avash Das; Shenglan Chen; Jingyuan Chen; Xinqun Hu; Fei Li; Zhenfei Fang; Shenhua Zhou
Journal:  J Cell Mol Med       Date:  2020-01-16       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.